Department of Pediatrics / Hematology/Oncology Division / Research Publications

Research Publications

More About Pediatric Hematology Oncology Investigators

View Investigators' Research Profiles.

1. Umeda M
2. Hiltenbrand R
3. Michmerhuizen NL
4. Barajas JM
5. Thomas Iii ME
6. Arthur B
7. Walsh MP
8. Song G
9. Ma J
10. Westover T
11. Kumar A
12. Pölönen P
13. Mecucci C
14. Di Giacomo D
15. Locatelli F
16. Masetti R
17. Bertuccio SN
18. Pigazzi M
19. Pruett-Miller SM
20. Pounds S
21. Rubnitz J
22. Inaba H
23. Papadopoulos KP
24. Wick MJ
25. Iacobucci I
26. Mullighan CG
27. Klco JM
Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia.; Blood; Vol 146(17), pp. 2102-2118. 2025 Oct 23.
1. Michmerhuizen NL
2. Heikamp EB
3. Iacobucci I
4. Umeda M
5. Arthur B
6. Mishra V
7. Park CS
8. Di Giacomo D
9. Hiltenbrand R
10. Gao Q
11. Radko-Juettner S
12. Lott J
13. Martucci C
14. Subramanyam V
15. Hatton C
16. Wenge DV
17. Baviskar P
18. Portola P
19. Claquin A
20. Chandra B
21. Baggett DW
22. Khalighifar A
23. Huang H
24. Zhou P
25. Long L
26. Shi H
27. Sun Y
28. Papachristou EK
29. Sekhar Reddy Chilamakuri C
30. de Luna Vitorino FN
31. Gongora JM
32. Wu H
33. Pounds SB
34. Janke LJ
35. Kentsis A
36. D'Santos CS
37. Garcia BA
38. Kriwacki RW
39. Chi H
40. Klco JM
41. Armstrong SA
42. Mullighan CG
KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia.; Cancer discovery; Vol 15(10), pp. 2096-2116. 2025 Oct 06.
1. Blanc L
2. Tang Y
3. Ling T
4. Mehmood R
5. Bertrand A
6. Papoin J
7. Khan M
8. Rao R
9. Xu J
10. Schulz V
11. Palis J
12. Steiner L
13. Barnes B
14. Zou Y
15. Marambaud P
16. Signer R
17. Roberts I
18. Iskander D
19. Zon L
20. Bhoopalan S
21. Weiss M
22. Lipton J
23. Gallagher P
24. Mohandas N
25. Taylor N
26. Durand S
27. Crispino J
RPS19 and RPL5 Haploinsufficient Models Reveal Divergent Ribosomal Subunit Controls of Fetal Hematopoiesis.; Research square. 2025 Sep 26.
1. Malloy M
2. McGrath KE
3. Morrell CN
Platelet Heterogeneity: Variety Makes Immune and Vascular Function Better.; Blood. 2025 Aug 26.
1. McGrath KE
2. Olsen JL
3. Koniski AD
4. Murphy KE
5. Getman M
6. An HH
7. Schulz VP
8. Kim AR
9. Zhang B
10. Carlson TL
11. Papoin J
12. Blanc L
13. Kingsley PD
14. Westhoff CM
15. Gallagher PG
16. Chou ST
17. Steiner LA
18. Palis J
BMI1 regulates human erythroid self-renewal through both gene repression and gene activation.; Nature communications; Vol 16(1), pp. 7619. 2025 Aug 15.
1. McMahon S
2. Gupta R
3. Zak E
4. Fries C
5. Alnasser D
6. Kaushal P
7. Wang H
8. Farris N
A Retrospective Single-Center Study of Ferric Derisomaltose in Adolescent Patients.; Pediatric blood & cancer. 2025 Jun 23.
1. Winter MA
2. Greenlee J
3. Al Ghriwati N
4. Carlson M
5. Sahler OJZ
6. O'Connor TG
Parent Resolution of Their Child's Cancer Diagnosis: Associations With Parent Stress and Quality of Life.; Journal of pediatric hematology/oncology nursing. 2025 Jun 12.
1. Fries C
Predicting T-ALL response to pre-TCR and IL-7R coinhibition.; Blood; Vol 145(24), pp. 2808-2810. 2025 Jun 12.
1. Duarte LS
2. Blumberg N
3. Marvald J
4. Love T
5. Andolina JR
6. Noronha SA
7. Steiner LA
8. Henrichs K
9. Looney RJ
10. Refaai MA
11. Asante A
Differences in outcomes associated with ABO blood groups in recipients of IVIG.; Blood vessels, thrombosis & hemostasis; Vol 2(3), pp. 100075. 2025 May 09.
1. Huang BJ
2. Meyer LK
3. Alonzo TA
4. Wang YC
5. Lamble AJ
6. Ries RE
7. Wang W
8. Hirsch B
9. Raca G
10. Ma X
11. Gamis AS
12. Aplenc R
13. Kolb EA
14. Cooper TM
15. Tarlock K
16. Loken MR
17. Meshinchi S
18. Chewning JH
19. Woods WG
20. Horan JT
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 43(17), pp. 1961-1971. 2025 Apr 28.
1. Bono MH
2. Reese S
3. Levonyan-Radloff K
4. Donovan KA
5. Sahler OJZ
6. Barnett ME
7. Collins M
8. Devine KA
"There's a lot of unknowns": a thematic analysis of the experiences of young adults with cancer who died during a psychosocial intervention trial.; BMC palliative care; Vol 24(1), pp. 98. 2025 Apr 09.
1. Kawano Y
2. Kawano H
3. LaMere MW
4. LaMere EA
5. Byun DK
6. McGrath K
7. Palis J
8. Bajaj J
9. Liesveld JL
10. Katayama Y
11. Yamazaki S
12. Kapur R
13. Calvi LM
14. Ho TC
15. Becker MW
IL-1R1 and IL-18 Signals Regulate Mesenchymal Stromal Cells in an Aged Murine Model of Myelodysplastic Syndromes.; Blood. 2025 Jan 22.
1. Wancura JN
2. Lemus OMD
3. Tanny SM
4. Yoon J
5. Webster MJ
6. Constine LS
7. Zheng D
Does extending the body contour into air enhance surface dose calculation accuracy?; Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2025 Jan 09.
1. Rivais W
2. Constine L
3. Pacella M
4. Joyce N
5. Nagey M
6. Webster M
7. Yoon J
8. Jung H
9. Tanny S
10. Lemus O
11. Zheng D
Comparative analysis of fetal dose sparing between a C-arm linac and an O-ring linac in a SIB-VMAT sarcoma treatment for a pregnant patient: A technical note and case report; J Appl Clin Med Phys; Vol 26(1). 2025 Jan 01.
1. Hoppe BS
2. Milgrom SA
3. Renfro LA
4. Wu Y
5. Schwartz CL
6. Constine LS
7. McCarten KM
8. Kelly KM
9. Hodgson D
10. Castellino SM
11. Keller FG
Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical Trial; JAMA Oncol; Vol 11(3), pp. 340-342. 2025 Jan 01.
1. DeVine A
2. Landier W
3. Hudson MM
4. Constine LS
5. Bhatia S
6. Armenian SH
7. Gramatges MM
8. Chow EJ
9. Friedman DN
10. Ehrhardt MJ
The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: A Review; JAMA Oncol; Vol 11(5), pp. 544-553. 2025 Jan 01.
1. Demoor-Goldschmidt C
2. Lamore K
3. Jakab Z
4. de Ville DG
5. M HS
6. Bathilde L
7. Berger C
8. Beek L
9. Beauchesne M
10. Borszekine CE
11. Brichard B
12. Constine LS
13. Te DJ
14. Favreau M
15. Grabow D
16. Hinckel L
17. Keresztes A
18. Ollivier L
19. Sauterey B
20. Skinner R
21. Thebault E
22. Thierry-Chef I
23. Trinh S
24. Zadravec ZL
25. Roganovic J
26. Chades-Esnault MC
27. Armand A
Addressing akrasia in childhood, adolescent and young ddult cancer survivors: implications for long-term follow-up and preventive health interventions; Cancers (Basel); Vol 17(8). 2025 Jan 01.
1. Bouchard EG
2. Prince MA
3. McCarty C
4. Collins L
5. Sahler O
6. Vincent PC
7. Patel H
8. LaValley SA
9. Krenz T
10. Devonish JA
11. Kelly KM
Socioeconomic inequalities in social support: Examining differences in social support network satisfaction and composition among pediatric cancer caregivers; J Psych Onc. 2025 Jan 01.
1. Winter MA
2. Greenlee J
3. Ghriwati NA
4. Carlson M
5. Sahler O
6. Korones D
7. Varon L
8. O'Connor TG
Parent resolution of their children's cancer diagnosis: Association with parent stress and quality of life; Journal of Pediatric Hematology/Oncology Nursing. 2025 Jan 01.
1. Yegya-Raman N
2. Plastaras JP
3. Wright CM
4. Chelius MR
5. Zhang S
6. Baron JA
7. Hubbeling H
8. Sim AJ
9. Robinson TJ
10. Jain MD
11. Imber BS
12. Fregonese B
13. Yahalom J
14. Ladbury C
15. Dandapani S
16. Pinnix CC
17. Gunther JR
18. Fang PQ
19. Wu SY
20. Dabaja BS
21. Yang JC
22. Chew J
23. Braunstein S
24. Sinha S
25. Denlinger N
26. Sun S
27. Terezakis SA
28. Sakthivel G
29. Constine LS
30. Chowdhry AK
31. Reagan PM
32. Burke S
33. Tseng YD
34. LaRiviere MJ
35. Maity A
36. Schuster SJ
37. Chong EA
38. Figura NB
Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study; Blood Adv; Vol 9(13), pp. 3293-3303. 2025 Jan 01.
1. van den OS
2. Mulder RL
3. Oeffinger KC
4. Gietema JA
5. Skinner R
6. Constine LS
7. Wallace WH
8. Armenian S
9. Barnea D
10. Bardi E
11. Belle FN
12. Brown AL
13. Chemaitilly W
14. Crowne L
15. van Dalen EC
16. Denzer C
17. Ehrhardt MJ
18. Felicetti F
19. Friedman DN
20. Fulbright J
21. Glaser AW
22. Giwercman A
23. Sangstuen HH
24. Hayek S
25. Hennewig U
26. van den HM
27. Haupt R
28. van Iersel L
29. Kamdar K
30. Lefrandt J
31. Levitt G
32. Morsellino V
33. Mulrooney DA
34. Murray RD
35. Neggers S
36. Ness KK
37. Neville KA
38. Nock NL
39. Otth M
40. Prasad PK
41. van Santen HM
42. et A
Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Eur J Endocrinol; Vol 192(4), pp. 27-40. 2025 Jan 01.
1. Kooijmans E
2. Mulder RL
3. Marks SD
4. Pavasovic V
5. Motwani SS
6. Walwyn T
7. Larkins NG
8. Kruseova J
9. Constine LS
10. Wallace WH
11. Green DM
12. Bökenkamp A
13. van der PH
14. van den HM
15. Hjorth L
16. Andrés-Jensen L
17. Bardi E
18. van Dalen EC
19. Demoor-Goldschmidt C
20. Becktell K
21. Grönroos M
22. Kieran K
23. Mironova D
24. Terenziani M
25. Veening MA
26. Zieg J
27. Onder S
28. Onder AM
29. Routh JC
30. Thompson J
31. Hudson MM
32. Kremer L
33. Skinner R
34. Ehrhardt MJ
Nephrotoxicity Surveillance for Childhood and Young Adult Survivors of Cancer: Recommendations From the International Late Effects of Childhood Cancer Guideline Harmonization Group; J Clin Oncol; Vol 43(21), pp. 2433-2448. 2025 Jan 01.
1. Wright AM
2. Mehringer J
3. Sahler OJ
4. Yussman S
Impact on adolescent medicine fellows of legislation restricting gender affirming care for minors; Journal of Adolescent Health and Medicine; Vol 76(Abstract 128), pp. 66-67. 2025 Jan 01.
1. Duarte LS
2. Fries C
3. Noronha S
Delayed Presentation of Transfusion-Associated Circulatory Overload Associated With Splenic Sequestration Management in Sickle Cell Disease.; Pediatric blood & cancer; Vol 72(2), pp. e31460. 2024 Nov 23.
1. Gensterblum-Miller E
2. Bhangale A
3. Majid DA
4. Pienkowski VM
5. Rydzanicz M
6. Janiszewska J
7. Kostrzewska-Poczekaj M
8. Chang C
9. Brummel C
10. Michmerhuizen NL
11. Wang J
12. Sandford E
13. Tewari M
14. Wierzbicka M
15. Birkeland AC
16. McHugh JB
17. Spector ME
18. Giefing M
19. Jarmuz-Szymczak M
20. Heft Neal ME
21. Brenner JC
Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma.; Oral oncology; Vol 159, pp. 107108. 2024 Nov 15.
1. Kean LS
2. Burns LJ
3. Kou TD
4. Kapikian R
5. Lozenski K
6. Langston A
7. Horan JT
8. Watkins B
9. Qayed M
10. Bratrude B
11. Betz K
12. Tang XY
13. Zhang MJ
14. Connolly SE
15. Polinsky M
16. Gavin B
17. Gomez-Caminero A
18. Pasquini MC
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.; Blood; Vol 144(17), pp. 1834-1845. 2024 Oct 24.
1. Herrera AF
2. LeBlanc M
3. Castellino SM
4. Li H
5. Rutherford SC
6. Evens AM
7. Davison K
8. Punnett A
9. Parsons SK
10. Ahmed S
11. Casulo C
12. Bartlett NL
13. Tuscano JM
14. Mei MG
15. Hess BT
16. Jacobs R
17. Saeed H
18. Torka P
19. Hu B
20. Moskowitz C
21. Kaur S
22. Goyal G
23. Forlenza C
24. Doan A
25. Lamble A
26. Kumar P
27. Chowdhury S
28. Brinker B
29. Sharma N
30. Singh A
31. Blum KA
32. Perry AM
33. Kovach A
34. Hodgson D
35. Constine LS
36. Shields LK
37. Prica A
38. Dillon H
39. Little RF
40. Shipp MA
41. Crump M
42. Kahl B
43. Leonard JP
44. Smith SM
45. Song JY
46. Kelly KM
47. Friedberg JW
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.; The New England journal of medicine; Vol 391(15), pp. 1379-1389. 2024 Oct 17.
1. Zhao N
2. Michelucci A
3. Pietrangelo L
4. Malik S
5. Groom L
6. Leigh J
7. O'Connor TN
8. Takano T
9. Kingsley PD
10. Palis J
11. Boncompagni S
12. Protasi F
13. Dirksen RT
An Orai1 gain-of-function tubular aggregate myopathy mouse model phenocopies key features of the human disease.; The EMBO journal. 2024 Oct 17.
1. Livada AC
2. McGrath KE
3. Malloy MW
4. Li C
5. Ture SK
6. Kingsley PD
7. Koniski AD
8. Vit LA
9. Nolan KE
10. Mickelsen D
11. Monette GE
12. Maurya P
13. Palis J
14. Morrell CN
Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models.; The Journal of clinical investigation. 2024 Sep 19.
1. Boull C
2. Chen Y
3. Im C
4. Geller A
5. Sapkota Y
6. Bates JE
7. Howell R
8. Arnold MA
9. Conces M
10. Constine LS
11. Robison L
12. Yasui Y
13. Armstrong GT
14. Neglia JP
15. Turcotte LM
Keratinocyte carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor study.; Journal of the American Academy of Dermatology; Vol 91(6), pp. 1125-1135. 2024 Aug 23.
1. Foley K
2. Adlowitz DG
3. Baker C
4. Rock PJ
5. Burack R
6. Fries C
High-throughput sequencing of archival cerebrospinal fluid specimens defines B-lymphoblastic leukemia clonal composition.; Pediatric blood & cancer. 2024 Aug 21.
1. Oh J
2. Skinner L
3. Gutkin PM
4. Jiang A
5. Donaldson SS
6. Loo BW
7. Wang YP
8. Ewongwo A
9. Bredfeldt JS
10. Breneman JC
11. Constine LS
12. Faught AM
13. Haas-Kogan D
14. Holmes JA
15. Krasin M
16. Larkin C
17. Marcus KJ
18. Maxim PG
19. McClelland S
20. Murphy B
21. Palmer JD
22. Perkins SM
23. Shen CJ
24. Terezakis S
25. Bush K
26. Hiniker SM
Integrating Audiovisual Immersion Into Pediatric Radiation Therapy Across Multiple Centers: Methodology, Timeliness, and Cost of the Audiovisual-Assisted Therapeutic Ambience in Radiation Therapy Prospective Multi-Institutional Trial.; Advances in radiation oncology; Vol 9(10), pp. 101589. 2024 Aug 10.
1. Devine KA
2. Ohman-Strickland P
3. Barnett M
4. Donovan KA
5. Thompson LMA
6. Manne SL
7. Kearney J
8. Levonyan-Radloff K
9. Diaz D
10. Dugad S
11. Sahler OJZ
Protocol of a Multisite Randomized Controlled Trial of Bright IDEAS-Young Adults: Problem-Solving Skills Training to Reduce Distress among Young Adults with Cancer.; Contemporary clinical trials; Vol 145, pp. 107656. 2024 Aug 05.
1. Palis J
Erythropoiesis in the mammalian embryo.; Experimental hematology. 2024 Jul 22.
1. Bentzen SM
2. Vogelius IR
3. Hodgson D
4. Howell R
5. Jackson A
6. Hua CH
7. Olch AJ
8. Ronckers C
9. Kremer L
10. Milano M
11. Marks LB
12. Constine LS
Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors: Introduction to the Scientific Issues in PENTEC.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 338-353. 2024 Jun 01.
1. Jackson A
2. Hua CH
3. Olch A
4. Yorke ED
5. Rancati T
6. Milano MT
7. Constine LS
8. Marks LB
9. Bentzen SM
Reporting Standards for Complication Studies of Radiation Therapy for Pediatric Cancer: Lessons From PENTEC.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 697-707. 2024 Jun 01.
1. Constine LS
2. Olch AJ
3. Marks LB
4. Jackson A
5. Bentzen SM
PENTEC Dedication and Acknowledgments.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 315. 2024 Jun 01.
1. Lucas JT
2. Abramson ZR
3. Epstein K
4. Morin CE
5. Jaju A
6. Lee JW
7. Lee CL
8. Sitaram R
9. Voss SD
10. Hudson MM
11. Constine LS
12. Hua CH
Imaging Assessment of Radiation Therapy-Related Normal Tissue Injury in Children: A PENTEC Visionary Statement.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 669-680. 2024 Jun 01.
1. Farris N
2. Sandell A
Mixed coagulopathy in patient with peroxisomal disorder, Zellweger syndrome.; Pediatric blood & cancer; Vol 71(8), pp. e31094. 2024 May 21.
1. Webster M
2. Dona Lemus OM
3. Zheng D
4. Wancura JN
5. Tanny S
6. Sakthivel G
7. Constine L
Case study with dosimetric analysis: Total body irradiation to a patient with a left ventricular assist device.; Clinical case reports; Vol 12(5), pp. e8868. 2024 May 15.
1. Wyatt KD
2. Birz S
3. Castellino SM
4. Henderson TO
5. Lucas JT
6. Pei Q
7. Zhou Y
8. Volchenboum SL
9. Furner B
10. Watkins M
11. Kelly KM
12. Flerlage JE
Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL).; Journal of the National Cancer Institute; Vol 116(5), pp. 642-646. 2024 May 08.
1. Bowden A
2. Zambito J
3. El-Feghaly J
4. Andolina JR
Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series.; Pediatric hematology and oncology; Vol 41(6), pp. 389-398. 2024 May 07.
1. Takahashi T
2. Watkins B
3. Bratrude B
4. Neuberg D
5. Hebert K
6. Betz K
7. Yu A
8. Choi SW
9. Davis J
10. Duncan C
11. Giller R
12. Grimley M
13. Harris AC
14. Jacobsohn D
15. Lalefar N
16. Farhadfar N
17. Pulsipher MA
18. Shenoy S
19. Petrovic A
20. Schultz KR
21. Yanik GA
22. Blazar BR
23. Horan JT
24. Langston A
25. Kean LS
26. Qayed M
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.; Transplantation and cellular therapy; Vol 31(2), pp. 109.e1-109.e13. 2024 Apr 06.
1. Binkley MS
2. Flerlage JE
3. Savage KJ
4. Akhtar S
5. Steiner R
6. Zhang XY
7. Dickinson M
8. Prica A
9. Major A
10. Hendrickson PG
11. Hopkins D
12. Ng A
13. Casulo C
14. Baron J
15. Roberts KB
16. Al Kendi J
17. Balogh A
18. Ricardi U
19. Torka P
20. Specht L
21. De Silva R
22. Pickard K
23. Blazin LJ
24. Henry M
25. Smith CM
26. Halperin D
27. Brady J
28. Brennan B
29. Senchenko MA
30. Reeves M
31. Hoppe BS
32. Terezakis S
33. Talaulikar D
34. Picardi M
35. Kirova Y
36. Fergusson P
37. Hawkes EA
38. Lee D
39. Doo NW
40. Barraclough A
41. Cheah CY
42. Ku M
43. Hamad N
44. Mutsando H
45. Gilbertson M
46. Marconi T
47. Viiala N
48. Maurer MJ
49. Eichenauer DA
50. Hoppe RT
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 42(19), pp. 2271-2280. 2024 Mar 26.
1. Reese S
2. Bono MH
3. Díaz DB
4. Donovan KA
5. Sahler OJZ
6. Barnett ME
7. Levonyan-Radloff K
8. Devine KA
Stop and Think: A Case Study Illustrating the Implementation of Bright IDEAS-YA Being Delivered via Telehealth to a Young Adult Cancer Patient.; Journal of clinical psychology in medical settings. 2024 Mar 16.
1. Gorfinkel L
2. Raghunandan S
3. Watkins B
4. Hebert K
5. Neuberg DS
6. Bratrude B
7. Betz K
8. Yu A
9. Choi SW
10. Davis J
11. Duncan C
12. Giller R
13. Grimley M
14. Harris AC
15. Jacobsohn D
16. Lalefar N
17. Farhadfar N
18. Pulsipher MA
19. Shenoy S
20. Petrovic A
21. Schultz KR
22. Yanik GA
23. Blazar BR
24. Horan JT
25. Langston A
26. Kean LS
27. Qayed M
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.; Bone marrow transplantation. 2024 Feb 21.
1. Williams AM
2. Liu W
3. Ehrhardt MJ
4. Mirzaei Salehabadi S
5. Panoskaltsis-Mortari A
6. Phillips NS
7. Mulrooney DA
8. Flerlage JE
9. Yasui Y
10. Srivastava DK
11. Robison LL
12. Hudson MM
13. Ness KK
14. Sabin ND
15. Krull KR
Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-term Survivors of Childhood Hodgkin Lymphoma.; Clinical cancer research : an official journal of the American Association for Cancer Research. 2024 Feb 21.
1. Otth M
2. Kasteler R
3. Mulder RL
4. Agrusa J
5. Armenian SH
6. Barnea D
7. Bergeron A
8. Bhatt NS
9. Bourke SJ
10. Constine LS
11. Goutaki M
12. Green DM
13. Hennewig U
14. Houdouin V
15. Hudson MM
16. Kremer L
17. Latzin P
18. Ng A
19. Oeffinger KC
20. Schindera C
21. Skinner R
22. Sommer G
23. Srinivasan S
24. Stokes DC
25. Versluys B
26. Waespe N
27. Weiner DJ
28. Dietz AC
29. Kuehni CE
Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.; EClinicalMedicine; Vol 69, pp. 102487. 2024 Feb 20.
1. Rossmann MP
2. Palis J
Developmental regulation of primitive erythropoiesis.; Current opinion in hematology. 2024 Feb 12.
1. McGrath KE
2. Koniski AD
3. Murphy K
4. Getman M
5. An HH
6. Schulz VP
7. Kim AR
8. Zhang B
9. Schofield TL
10. Papoin J
11. Blanc L
12. Kingsley PD
13. Westhoff CM
14. Gallagher PG
15. Chou ST
16. Steiner LA
17. Palis J
BMI1 regulates human erythroid self-renewal through both gene repression and gene activation.; bioRxiv : the preprint server for biology. 2024 Feb 06.
1. Lo AC
2. Liu A
3. Liu Q
4. Yasui Y
5. Castellino SM
6. Kelly KM
7. Hererra AF
8. Friedberg JW
9. Friedman DL
10. Schwartz CL
11. Pei Q
12. Kessel S
13. Bergeron-Gravel S
14. Dama H
15. Roberts K
16. Constine LS
17. Hodgson DC
Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children.; JAMA network open; Vol 7(1), pp. e2351062. 2024 Jan 02.
1. Milano MT
2. Vargo JA
3. Yorke ED
4. Ronckers CM
5. Kremer LC
6. Chafe S
7. van Santen HM
8. Marks LB
9. Bentzen SM
10. Constine LS
11. Vogelius IR
Primary hypothyroidism in childhood cancer survivors treated with radiotherapy: A PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Constine LS
2. Olch AJ
3. Jackson A
4. Hua CH
5. Ronckers C
6. Milano MT
7. Marcus KJ
8. Yorke E
9. Hodgson D
10. Howell R
11. Hudson M
12. Williams J
13. Marples B
14. Kremer L
15. Marks LB
16. Bentzen SM
Pediatric Normal Tissue Effects in the Clinic (PENTEC): an international collaboration to assess normal tissue radiation dose-volume-response relationships for children with cancer; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Milgrom SA
2. van Luijk P
3. Pino R
4. Ronckers CM
5. Kremer LC
6. Gidley PW
7. Grosshans DR
8. Laskar S
9. Okcu MF
10. Constine LS
11. Paulino AC
Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A Pediatric Normal Tissue Effects in the Clinic (PENTEC) Comprehensive Review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Lo AC
2. Ronckers C
3. Aznar MC
4. Avanzo M
5. van Dijk I
6. Kremer L
7. Gagliardi G
8. Howell RM
9. Rancati T
10. Constine LS
11. Marcus KJ
Breast hypoplasia and decreased lactation from radiation therapy in survivors of pediatric malignancy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Mahajan A
2. Stavinoha PL
3. Rongthong W
4. Brodin NP
5. McGovern SL
6. El NI
7. Palmer JD
8. Vennarini S
9. Indelicato DJ
10. Aridgides P
11. Bowers DC
12. Kremer L
13. Ronckers C
14. Constine L
15. Avanzo M
Neurocognitive effects and necrosis in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Briere TM
2. Agrusa JE
3. Martel MK
4. Jackson A
5. Olch AJ
6. Ronckers CM
7. Kremer L
8. Constine LS
9. McAleer MF
Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Milano MT
2. Marks LB
3. Olch AJ
4. Yorke ED
5. Jackson A
6. Bentzen SM
7. Constine LS
Comparison of Risks of Late Effects From Radiation Therapy in Children Versus Adults: Insights From the QUANTEC, HyTEC, and PENTEC Efforts; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Nanda RH
2. Hua CH
3. Flampouri S
4. Eaton B
5. Kaste S
6. Patni T
7. Ronckers C
8. Constine LS
9. Marks LB
10. Esiashvili N
Risks of Spinal Abnormalities and Growth Impairment After Radiation to the Spine in Childhood Cancer Survivors: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Hua CH
2. Bentzen SM
3. Li Y
4. Milano MT
5. Rancati T
6. Marks LB
7. Constine LS
8. Yorke ED
9. Jackson A
Improving Pediatric Normal Tissue Radiation Dose-Response Modeling in Children With Cancer: A PENTEC Initiative .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Ajithkumar T
2. Avanzo M
3. Yorke E
4. Tsang DS
5. Milano MT
6. Olch AJ
7. Merchant TE
8. Dieckmann K
9. Mahajan A
10. Fuji H
11. Paulino AC
12. Timmermann B
13. Marks LB
14. Bentzen SM
15. Jackson A
16. Constine LS
Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Cooper BT
2. Mayo CS
3. Milano MT
4. Olch AJ
5. Oh C
6. Keating GF
7. Hallstrom A
8. Constine LS
9. Laack NN
Predictive Factors Associated With Radiation Myelopathy in Pediatric Patients With Cancer: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Lo AC
2. Liu A
3. Liu Q
4. Yasui Y
5. Castellino SM
6. Kelly KM
7. Hererra AF
8. Friedberg JW
9. Friedman DL
10. Schwartz CL
11. Pei Q
12. Kessel S
13. Bergeron-Gravel S
14. Dama H
15. Roberts K
16. Constine LS
17. Hodgson DC
Cardiac Toxicity Associated with Treatment Protocols for Hodgkin Lymphoma in Children; JAMA Network Open; Vol in press. 2024 Jan 01.
1. Bates JE
2. Marples B
3. Hudson MM
4. Williams AM
5. Marcus K
6. Howell R
7. Paulino A
8. Constine LS
PENTEC: Biodevelopmental Considerations in Pediatric Patients with Cancer and Childhood Cancer Survivors; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Constine LS
2. Marks LB
3. Milano MT
4. Ronckers CM
5. Jackson A
6. Hudson MM
7. Marcus KJ
8. Hodgson DC
9. Hua CH
10. Howell RM
11. Marples B
12. Yorke E
13. Olch A
14. Bentzen SM
A User's Guide and Summary of Pediatric Normal Tissue Effects in the Clinic (PENTEC): Radiation Dose-Volume Response for Adverse Effects After Childhood Cancer Therapy and Future Directions; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Murphy B
2. Jackson A
3. Bass JK
4. Tsang DS
5. Ronckers CM
6. Kremer L
7. Baliga S
8. Olch A
9. Zureick AH
10. Jee KW
11. Constine LS
12. Yock TI
Modeling the risk of hearing loss from radiation therapy in childhood cancer survivors: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Hill-Kayser C
2. Yorke E
3. Jackson A
4. Gracia C
5. Ginsberg J
6. Keene K
7. Ronckers C
8. Metzger ML
9. Li Z
10. Constine L
11. Hua CH
Effects of radiation therapy on the female reproductive tract in childhood cancer survivors: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Baliga S
2. Patel S
3. Naqa IE
4. Li XA
5. Cohen LE
6. Howell RM
7. Hoppe BS
8. Constine LS
9. Palmer JD
10. Hamstra D
11. Olch AJ
Testicular dysfunction in male childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Casey DL
2. Vogelius IR
3. Brodin NP
4. Roberts KB
5. Avanzo M
6. Moni J
7. Owens C
8. Ronckers CM
9. Constine LS
10. Bentzen SM
11. Olch A
Risk of subsequent neoplasms in childhood cancer survivors after radiation therapy: a comprehensive PENTEC review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Shen CJ
2. Kry SF
3. Buchsbaum JC
4. Milano MT
5. Inskip PD
6. Ulin K
7. Francis JH
8. Wilson MW
9. Whelan KF
10. Mayo CS
11. Olch AJ
12. Constine LS
13. Terezakis SA
14. Vogelius IR
Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 431-445. 2024 Jan 01.
1. Bates JE
2. Marples B
3. Hudson MM
4. Williams AM
5. Marcus K
6. Howell R
7. Paulino A
8. Constine LS
Biodevelopmental Considerations in Pediatric Patients With Cancer and Childhood Cancer Survivors: A PENTEC Introductory Review; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 354-359. 2024 Jan 01.
1. Constine LS
2. Marks LB
3. Milano MT
4. Ronckers CM
5. Jackson A
6. Hudson MM
7. Marcus KJ
8. Hodgson DC
9. Hua CH
10. Howell RM
11. Marples B
12. Yorke E
13. Olch A
14. Bentzen SM
A User's Guide and Summary of Pediatric Normal Tissue Effects in the Clinic (PENTEC): Radiation Dose-Volume Response for Adverse Effects After Childhood Cancer Therapy and Future Directions; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 321-337. 2024 Jan 01.
1. Milano MT
2. Marks LB
3. Olch AJ
4. Yorke ED
5. Jackson A
6. Bentzen SM
7. Constine LS
Comparison of Risks of Late Effects From Radiation Therapy in Children Versus Adults: Insights From the QUANTEC, HyTEC, and PENTEC Efforts; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 387-400. 2024 Jan 01.
1. Hua CH
2. Bentzen SM
3. Li Y
4. Milano MT
5. Rancati T
6. Marks LB
7. Constine LS
8. Yorke ED
9. Jackson A
Improving Pediatric Normal Tissue Radiation Dose-Response Modeling in Children With Cancer: A PENTEC Initiative; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 369-386. 2024 Jan 01.
1. Ajithkumar T
2. Avanzo M
3. Yorke E
4. Tsang DS
5. Milano MT
6. Olch AJ
7. Merchant TE
8. Dieckmann K
9. Mahajan A
10. Fuji H
11. Paulino AC
12. Timmermann B
13. Marks LB
14. Bentzen SM
15. Jackson A
16. Constine LS
Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 655-668. 2024 Jan 01.
1. Cooper BT
2. Mayo CS
3. Milano MT
4. Olch AJ
5. Oh C
6. Keating GF
7. Hallstrom A
8. Constine LS
9. Laack NN
Predictive Factors Associated With Radiation Myelopathy in Pediatric Patients With Cancer: A PENTEC Comprehensive Review; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 494-506. 2024 Jan 01.
1. Shen CJ
2. Kry SF
3. Buchsbaum JC
4. Milano MT
5. Inskip PD
6. Ulin K
7. Francis JH
8. Wilson MW
9. Whelan KF
10. Mayo CS
11. Olch AJ
12. Constine LS
13. Terezakis SA
14. Vogelius IR
Retinopathy, optic neuropathy, and cataract in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Hall MD
2. Howell RM
3. Jackson A
4. Owens CA
5. Hernandez S
6. Castellino SM
7. Ronckers CM
8. Constine LS
9. Bradley JA
Liver late effects in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Poppe MM
2. Tai A
3. Li XA
4. Miften M
5. Olch A
6. Marks LB
7. Qureshi BM
8. Spunt SL
9. Shnorhavorian M
10. Nelson G
11. Ronckers C
12. Kalapurakal J
13. Marples B
14. Constine LS
15. Liu AK
Kidney disease in childhood cancer survivors treated with radiation therapy: a comprehensive PENTEC genitourinary review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Wheeler G
2. Grassberger C
3. Samers J
4. Dwyer M
5. Wiltshire K
6. Daly P
7. Alvarez B
8. Campbell BA
9. Kerr AJ
10. Kron T
11. Duane FK
12. Zacharin M
13. Downie P
14. Kyriakou E
15. Ronckers CM
16. Constine LS
17. Hiniker SM
Central endocrine complications among childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Bates JE
2. Rancati T
3. Keshavarz H
4. Gagliardi G
5. Aznar MC
6. Howell RM
7. Shrestha S
8. Moiseenko V
9. Yorke E
10. Armenian S
11. Kremer L
12. Chen MH
13. van der PH
14. Cutter DJ
15. Constine LS
16. Hodgson D
Cardiac disease in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Ehler ED
2. Turcotte LM
3. Skamene S
4. Baker KS
5. Das SK
6. Constine LS
7. Yuan J
8. Dusenbery KE
Idiopathic pneumonitis syndrome after total body irradiation in pediatric patients undergoing myeloablative hematopoietic stem cell transplantation: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Waxer JF
2. Wong K
3. Modiri A
4. Charpentier AM
5. Moiseenko V
6. Ronckers CM
7. Taddei PJ
8. Constine LS
9. Sprow G
10. Tamrazi B
11. MacDonald S
12. Olch AJ
Risk of cerebrovascular events among childhood and adolescent patients receiving cranial radiation therapy: a Pediatric Normal Tissue Effects in the Clinic normal tissue outcomes comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
1. Oh J
2. Skinner L
3. Gutkin PM
4. Jiang A
5. Donaldson SS
6. Loo BJ
7. Wang YP
8. Ewongwo A
9. Bredfeldt JS
10. Breneman JC
11. Constine LS
12. Faught AM
13. Haas-Kogan D
14. Holmes JA
15. Krasin M
16. Larkin C
17. Marcus KJ
18. Maxim PG
19. McClelland S
20. rd MB
21. Palmer JD
22. Perkins SM
23. Shen CJ
24. Terezakis S
25. Bush K
26. Hiniker SM
Integrating Audiovisual Immersion Into Pediatric Radiation Therapy Across Multiple Centers: Methodology, Timeliness, and Cost of the Audiovisual-Assisted Therapeutic Ambience in Radiation Therapy Prospective Multi-Institutional Trial; Advances in radiation oncology; Vol 9(10). 2024 Jan 01.
1. Nanda RH
2. Hua CH
3. Flampouri S
4. Eaton B
5. Kaste S
6. Patni T
7. Ronckers C
8. Constine LS
9. Marks LB
10. Esiashvili N
Risks of Spinal Abnormalities and Growth Impairment After Radiation to the Spine in Childhood Cancer Survivors: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 507-521. 2023 Dec 08.
1. Murphy B
2. Jackson A
3. Bass JK
4. Tsang DS
5. Ronckers CM
6. Kremer L
7. Baliga S
8. Olch A
9. Zureick AH
10. Jee KW
11. Constine LS
12. Yock TI
Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 446-456. 2023 Oct 19.
1. Ludwig ML
2. Michmerhuizen NL
3. Wang J
4. Birkeland AC
5. Majchrowski BK
6. Nimmagadda S
7. Zhai J
8. Bhangale A
9. Kulkarni A
10. Jiang H
11. Swiecicki PL
12. Brenner JC
Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma.; Archives of oral biology; Vol 156, pp. 105822. 2023 Oct 11.
1. Hill-Kayser C
2. Yorke E
3. Jackson A
4. Gracia C
5. Ginsberg J
6. Keene K
7. Ronckers C
8. Metzger ML
9. Li Z
10. Constine LS
11. Hua CH
Effects of Radiation Therapy on the Female Reproductive Tract in Childhood Cancer Survivors: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 588-609. 2023 Oct 05.
1. Baliga S
2. Patel S
3. Naqa IE
4. Li XA
5. Cohen LE
6. Howell RM
7. Hoppe BS
8. Constine LS
9. Palmer JD
10. Hamstra D
11. Olch AJ
Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 610-624. 2023 Oct 03.
1. Casey DL
2. Vogelius IR
3. Brodin NP
4. Roberts KB
5. Avanzo M
6. Moni J
7. Owens C
8. Ronckers CM
9. Constine LS
10. Bentzen SM
11. Olch A
Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 640-654. 2023 Sep 29.
1. Lv X
2. Murphy K
3. Murphy Z
4. Getman MR
5. Rahman NF
6. Nakamura Y
7. Blanc L
8. Gallagher PG
9. Palis J
10. Mohandas N
11. Steiner LA
HEXIM1 is an Essential Transcription Regulator During Human Erythropoiesis.; Blood. 2023 Sep 22.
1. Wang Y
2. Ronckers CM
3. van Leeuwen FE
4. Moskowitz CS
5. Leisenring W
6. Armstrong GT
7. de Vathaire F
8. Hudson MM
9. Kuehni CE
10. Arnold MA
11. Demoor-Goldschmidt C
12. Green DM
13. Henderson TO
14. Howell RM
15. Ehrhardt MJ
16. Neglia JP
17. Oeffinger KC
18. van der Pal HJH
19. Robison LL
20. Schaapveld M
21. Turcotte LM
22. Waespe N
23. Kremer LCM
24. Teepen JC
Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer.; Nature medicine; Vol 29(9), pp. 2268-2277. 2023 Sep 11.
1. Raghunandan S
2. Gorfinkel L
3. Graiser M
4. Bratrude B
5. Suessmuth Y
6. Gillespie S
7. Westbrook AL
8. Williams KM
9. Schoettler ML
10. Kean LS
11. Horan J
12. Langston AA
13. Qayed M
14. Watkins B
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.; Blood advances; Vol 7(16), pp. 4395-4399. 2023 Aug 22.
1. Goh I
2. Botting RA
3. Rose A
4. Webb S
5. Engelbert J
6. Gitton Y
7. Stephenson E
8. Quiroga Londoño M
9. Mather M
10. Mende N
11. Imaz-Rosshandler I
12. Yang L
13. Horsfall D
14. Basurto-Lozada D
15. Chipampe NJ
16. Rook V
17. Lee JTH
18. Ton ML
19. Keitley D
20. Mazin P
21. Vijayabaskar MS
22. Hannah R
23. Gambardella L
24. Green K
25. Ballereau S
26. Inoue M
27. Tuck E
28. Lorenzi V
29. Kwakwa K
30. Alsinet C
31. Olabi B
32. Miah M
33. Admane C
34. Popescu DM
35. Acres M
36. Dixon D
37. Ness T
38. Coulthard R
39. Lisgo S
40. Henderson DJ
41. Dann E
42. Suo C
43. Kinston SJ
44. Park JE
45. Polanski K
46. Marioni J
47. van Dongen S
48. Meyer KB
49. de Bruijn M
50. Palis J
51. Behjati S
52. Laurenti E
53. Wilson NK
54. Vento-Tormo R
55. Chédotal A
56. Bayraktar O
57. Roberts I
58. Jardine L
59. Göttgens B
60. Teichmann SA
61. Haniffa M
Yolk sac cell atlas reveals multiorgan functions during human early development.; Science (New York, N.Y.); Vol 381(6659), pp. eadd7564. 2023 Aug 18.
1. Raghunandan S
2. Gorfinkel L
3. Bratrude B
4. Suessmuth Y
5. Hebert K
6. Neuberg D
7. Williams KM
8. Schoettler ML
9. Langston AA
10. Kean LS
11. Qayed M
12. Horan J
13. Watkins BK
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.; Bone marrow transplantation. 2023 Aug 14.
1. Raghunandan S
2. Qayed M
3. Watkins BK
4. Graiser M
5. Gorfinkel L
6. Westbrook A
7. Gillespie S
8. Bratrude B
9. Petrovic A
10. Suessmuth Y
11. Horan J
12. Kean LS
13. Langston AA
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.; Bone marrow transplantation. 2023 Aug 14.
1. Bourne JH
2. Campos J
3. Hopkin SJ
4. Whitworth K
5. Palis J
6. Senis YA
7. Rayes J
8. Iqbal AJ
9. Brill A
Megakaryocyte NLRP3 hyperactivation induces mild anemia and potentiates inflammatory response in mice.; Frontiers in immunology; Vol 14, pp. 1226196. 2023 Aug 09.
1. Geerlinks AV
2. Scull B
3. Krupski C
4. Fleischmann R
5. Pulsipher MA
6. Eapen M
7. Connelly JA
8. Bollard CM
9. Pai SY
10. Duncan CN
11. Kean LS
12. Baker KS
13. Burroughs LM
14. Andolina JR
15. Shenoy S
16. Roehrs P
17. Hanna R
18. Talano JA
19. Schultz KR
20. Stenger EO
21. Lin H
22. Zoref-Lorenz A
23. McClain KL
24. Jordan MB
25. Man TK
26. Allen CE
27. Marsh RA
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT.; Blood advances; Vol 7(14), pp. 3725-3734. 2023 Jul 25.
1. Hall MD
2. Howell RM
3. Jackson A
4. Owens CA
5. Hernandez S
6. Castellino SM
7. Ronckers CM
8. Constine LS
9. Bradley JA
Liver Late Effects in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 575-587. 2023 Jul 20.
1. Poppe MM
2. Tai A
3. Li XA
4. Miften M
5. Olch A
6. Marks LB
7. Qureshi BM
8. Spunt SL
9. Shnorhavorian M
10. Nelson G
11. Ronckers C
12. Kalapurakal J
13. Marples B
14. Constine LS
15. Liu AK
Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 560-574. 2023 Jul 14.
1. Fries C
2. Hermiston ML
Challenging T-ALL to IL-7Rp dual inhibition.; Blood; Vol 142(2), pp. 124-126. 2023 Jul 13.
1. Thakar MS
2. Logan BR
3. Puck JM
4. Dunn EA
5. Buckley RH
6. Cowan MJ
7. O'Reilly RJ
8. Kapoor N
9. Satter LF
10. Pai SY
11. Heimall J
12. Chandra S
13. Ebens CL
14. Chellapandian D
15. Williams O
16. Burroughs LM
17. Saldana BD
18. Rayes A
19. Madden LM
20. Chandrakasan S
21. Bednarski JJ
22. DeSantes KB
23. Cuvelier GDE
24. Teira P
25. Gillio AP
26. Eissa H
27. Knutsen AP
28. Goldman FD
29. Aquino VM
30. Shereck EB
31. Moore TB
32. Caywood EH
33. Lugt MTV
34. Rozmus J
35. Broglie L
36. Yu LC
37. Shah AJ
38. Andolina JR
39. Liu X
40. Parrott RE
41. Dara J
42. Prockop S
43. Martinez CA
44. Kapadia M
45. Jyonouchi SC
46. Sullivan KE
47. Bleesing JJ
48. Chaudhury S
49. Petrovic A
50. Keller MD
51. Quigg TC
52. Parikh S
53. Shenoy S
54. Seroogy C
55. Rubin T
56. Decaluwe H
57. Routes JM
58. Torgerson TR
59. Leiding JW
60. Pulsipher MA
61. Kohn DB
62. Griffith LM
63. Haddad E
64. Dvorak CC
65. Notarangelo LD
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.; Lancet (London, England); Vol 402(10396), pp. 129-140. 2023 Jun 20.
1. Takahashi T
2. Al-Kofahi M
3. Jaber M
4. Bratrude B
5. Betz KM
6. Suessmuth Y
7. Yu A
8. Neuberg DS
9. Choi SW
10. Davis JH
11. Duncan C
12. Giller RH
13. Grimley M
14. Harris AC
15. Jacobsohn DA
16. Lalefar NR
17. Farhadfar N
18. Pulsipher MA
19. Shenoy S
20. Petrovic A
21. Schultz KR
22. Yanik GA
23. Blazar BR
24. Horan JT
25. Watkins B
26. Langston A
27. Qayed M
28. Kean LS
Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.; Blood. 2023 Jun 15.
1. Wheeler G
2. Grassberger C
3. Samers J
4. Dwyer M
5. Wiltshire K
6. Daly P
7. Alvarez B
8. Campbell BA
9. Kerr AJ
10. Kron T
11. Duane FK
12. Zacharin M
13. Downie P
14. Kyriakou E
15. Ronckers CM
16. Constine LS
17. Hiniker SM
Central Endocrine Complications Among Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 457-466. 2023 Jun 03.
1. Noronha SA
2. Strouse JJ
Fever in Children With Sickle Cell Disease-Rethinking the Approach When Bacteremia Is Rare.; JAMA network open; Vol 6(6), pp. e2318837. 2023 Jun 01.
1. Stenger EO
2. Watkins B
3. Rogowski K
4. Chiang KY
5. Haight A
6. Leung K
7. Qayed M
8. Raghunandan S
9. Suessmuth Y
10. Kean L
11. Horan J
Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.; Blood advances; Vol 7(10), pp. 2196-2205. 2023 May 23.
1. Purvis KN
2. Swanson HD
3. Niloy KK
4. Zhou Y
5. Panetta JC
6. Crews KR
7. Flerlage JE
Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.; Cancer chemotherapy and pharmacology; Vol 92(1), pp. 1-6. 2023 May 18.
1. Devine KJ
2. Fries C
3. Hermiston M
4. Wistinghausen B
How I approach B-lymphoblastic lymphoma in children.; Pediatric blood & cancer. 2023 May 09.
1. Bates JE
2. Rancati T
3. Keshavarz H
4. Gagliardi G
5. Aznar MC
6. Howell RM
7. Shrestha S
8. Moiseenko V
9. Yorke E
10. Armenian S
11. Kremer L
12. Chen MH
13. van der Pal HJ
14. Cutter DJ
15. Constine LS
16. Hodgson D
Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 522-532. 2023 Apr 14.
1. Ehler ED
2. Turcotte LM
3. Skamene S
4. Baker KS
5. Das SK
6. Constine LS
7. Yuan J
8. Dusenbery KE
Idiopathic Pneumonitis Syndrome After Total Body Irradiation in Pediatric Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 625-639. 2023 Mar 26.
1. Maurya P
2. Ture SK
3. Li C
4. Scheible KM
5. McGrath KE
6. Palis J
7. Morrell CN
Transfusion of Adult, but Not Neonatal, Platelets Promotes Monocyte Trafficking in Neonatal Mice.; Arteriosclerosis, thrombosis, and vascular biology. 2023 Mar 23.
1. Flerlage JE
2. Myers JR
3. Maciaszek JL
4. Oak N
5. Rashkin SR
6. Hui Y
7. Wang YD
8. Chen W
9. Wu G
10. Chang TC
11. Hamilton K
12. Tithi SS
13. Goldin LR
14. Rotunno M
15. Caporaso N
16. Vogt A
17. Flamish D
18. Wyatt K
19. Liu J
20. Tucker M
21. Hahn CN
22. Brown AL
23. Scott HS
24. Mullighan C
25. Nichols KE
26. Metzger ML
27. McMaster ML
28. Yang JJ
29. Rampersaud E
Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.; Blood; Vol 141(11), pp. 1293-1307. 2023 Mar 16.
1. Farris N
2. Benoit SW
3. McNinch NL
4. Bodas P
Urinary Biomarkers for the Assessment of Acute Kidney Injury of Pediatric Sickle Cell Anemia Patients Admitted for Severe Vaso-occlusive Crises.; Journal of pediatric hematology/oncology; Vol 45(6), pp. 309-314. 2023 Feb 20.
1. Buoninfante OA
2. Pilzecker B
3. Spanjaard A
4. de Groot D
5. Prekovic S
6. Song JY
7. Lieftink C
8. Ayidah M
9. Pritchard CEJ
10. Vivié J
11. Mcgrath KE
12. Huijbers IJ
13. Philipsen S
14. von Lindern M
15. Zwart W
16. Beijersbergen RL
17. Palis J
18. van den Berk PCM
19. Jacobs H
Mammalian life depends on two distinct pathways of DNA damage tolerance.; Proceedings of the National Academy of Sciences of the United States of America; Vol 120(4), pp. e2216055120. 2023 Jan 20.
1. Holloway MR
2. Fountaine T
3. Henrichs K
4. Feeney T
5. Andolina J
6. O'Dwyer K
7. Liesveld J
8. Blumberg N
9. Huselton E
Association of crystalloid fluid infusion with intravascular hemolysis and organ dysfunction in hematopoietic stem cell transplant patients.; Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2023 Jan 13.
1. Papoin J
2. Yan H
3. Leduc M
4. Le Gall M
5. Narla A
6. Palis J
7. Steiner LA
8. Gallagher PG
9. Hillyer CD
10. Gautier EF
11. Mohandas N
12. Blanc L
Phenotypic and proteomic characterization of the human erythroid progenitor continuum reveal dynamic changes in cell cycle and in metabolic pathways.; American journal of hematology. 2023 Jan 06.
1. Gutkin PM
2. Skinner L
3. Jiang A
4. Donaldson SS
5. Loo BJ
6. Oh J
7. Wang YP
8. von ER
9. Snyder J
10. Bredfeldt JS
11. Breneman JC
12. Constine LS
13. Faught AM
14. Haas-Kogan D
15. Holmes JA
16. Krasin M
17. Larkin C
18. Marcus KJ
19. Maxim PG
20. McClelland S
21. rd MB
22. Palmer JD
23. Perkins SM
24. Shen CJ
25. Terezakis S
26. Bush K
27. Hiniker SM
Feasibility of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) System for anesthesia avoidance in pediatric patients: a multicenter trial; Int J Radiat Oncol Biol Phys; Vol 117(1), pp. 96-104. 2023 Jan 01.
1. Mailhot VR
2. Harker-Murray PD
3. Forlenza CJ
4. Cole P
5. Kelly KM
6. Milgrom SA
7. Parikh RR
8. Hodgson DC
9. Castellino SM
10. Kahn J
11. Roberts KB
12. Constine LS
13. Hoppe BS
Radiation therapy use in refractory and relapsed adolescent and young adult Hodgkin lymphoma: a report from the Children's Oncology Group; Int J Radiat Oncol Biol Phys; Vol 117(2), pp. 400-403. 2023 Jan 01.
1. Reilly M
2. Dandapani SV
3. Kumar KA
4. Constine L
5. Fogh SE
6. Roberts KB
7. Small WJ
8. Schechter NR
ACR-ARS practice parameter for the performance of total body irradiation; Am J Clin Oncol; Vol 46(5), pp. 185-192. 2023 Jan 01.
1. Bates JE
2. Shrestha S
3. Liu Q
4. Smith SA
5. Mulrooney DA
6. Leisenring W
7. Gibson T
8. Robison LL
9. Chow EJ
10. Oeffinger KC
11. Armstrong GT
12. Constine LS
13. Hoppe BS
14. Lee C
15. Yasui Y
16. Howell RM
Cardiac substructure radiation dose and risk of late cardiac disease in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study; J Clin Oncol; Vol 41(22), pp. 3826-3838. 2023 Jan 01.
1. Chow EJ
2. Aggarwal S
3. Doody DR
4. Aplenc R
5. Armenian SH
6. Baker KS
7. Bhatia S
8. Blythe N
9. Colan SD
10. Constine LS
11. Freyer DR
12. Kopp LM
13. Laverdière C
14. Leisenring WM
15. Sasaki N
16. Vrooman LM
17. Asselin BL
18. Schwartz CL
19. Lipshultz SE
Dexrazoxane and long-term heart function in survivors of childhood cancer; J Clin Oncol; Vol 41(12), pp. 2248-2257. 2023 Jan 01.
1. Ehrhardt MJ
2. Leerink JM
3. Mulder RL
4. Mavinkurve-Groothuis A
5. Kok W
6. Nohria A
7. Nathan PC
8. Merkx R
9. de Baat E
10. Asogwa OA
11. Skinner R
12. Wallace H
13. Lieke FE
14. de Ville DG
15. M PM
16. Bárdi E
17. Pavasovic V
18. van der PH
19. Fresneau B
20. Demoor-Goldschmidt C
21. Hennewig U
22. Steinberger J
23. Plummer C
24. Chen MH
25. Teske AJ
26. Haddy N
27. van Dalen EC
28. Constine LS
29. Chow EJ
30. Levitt G
31. Hudson MM
32. Kremer L
33. Armenian SH
Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 24(3), pp. 108-120. 2023 Jan 01.
1. Cohen-Cutler S
2. Kaplan C
3. Olch A
4. Wong K
5. Malvar J
6. Constine LS
7. Freyer DR
Impact of volumetric dosimetry on the projected cost of radiation-related late effects screening after childhood cancer: a real-world cohort analysis; Oncologist; Vol 28(9), pp. 784-792. 2023 Jan 01.
1. Bouchard EG
2. Prince MA
3. McCarty C
4. Vincent PC
5. Patel H
6. LaValley SA
7. Collins RL
8. Sahler OJZ
9. Krenz T
10. Kelly KM
Understanding social network support, composition, and structure among cancer caregivers.; Psycho-oncology. 2023 Jan 01.
1. Werk RS
2. Koyama T
3. Sun L
4. Wolden S
5. Kelly KM
6. Constine LS
7. Schwartz CL
8. Friedman DL
Post-traumatic stress symptoms in adolescent Hodgkin lymphoma survivors: a report from Children's Oncology Group AHOD0031; J Adolesc Young Adult Oncol; Vol 12(3), pp. 359-365. 2023 Jan 01.
1. Chow EJ
2. Aggarwal S
3. Doody DR
4. Aplenc R
5. Armenian SH
6. Baker KS
7. Bhatia S
8. Blythe N
9. Colan SD
10. Constine LS
11. Freyer DR
12. Kopp LM
13. Laverdière C
14. Leisenring WM
15. Sasaki N
16. Vrooman LM
17. Asselin BL
18. Schwartz CL
19. Lipshultz SE
Dexrazoxane and long-term heart function in survivors of childhood cancer; J Clin Oncol; Vol 41(12), pp. 2248-2257. 2023 Jan 01.
1. Vassantachart A
2. Olch AJ
3. Jones M
4. Marques C
5. Ronckers C
6. Constine LS
7. Maduro JH
8. de Boer C
9. Wong K
A comprehensive review of 30 years of pediatric clinical trial radiotherapy dose constraints; Pediatr Blood Cancer; Vol 70(5). 2023 Jan 01.
1. Kwok G
2. Reese S
3. Dugad S
4. Donovan KA
5. Tsui J
6. Sahler OJZ
7. Levonyan-Radloff K
8. Barnett ME
9. Manne S
10. Ohman-Strickland P
11. Devine KA
Factors Associated with COVID‑19 Vaccine Uptake Among Adolescents and Young Adults Recently Diagnosed with Cancer.; Journal of adolescent and young adult oncology; Vol 13(2), pp. 352-357. 2022 Nov 11.
1. Waxer JF
2. Wong K
3. Modiri A
4. Charpentier AM
5. Moiseenko V
6. Ronckers CM
7. Taddei PJ
8. Constine LS
9. Sprow G
10. Tamrazi B
11. MacDonald S
12. Olch AJ
Risk of Cerebrovascular Events Among Childhood and Adolescent Patients Receiving Cranial Radiation Therapy: A PENTEC Normal Tissue Outcomes Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 417-430. 2022 Sep 01.
1. Geier CB
2. Ellison M
3. Cruz R
4. Pawar S
5. Leiss-Piller A
6. Zmajkovicova K
7. McNulty SM
8. Yilmaz M
9. Evans MO
10. Gordon S
11. Ujhazi B
12. Wiest I
13. Abolhassani H
14. Aghamohammadi A
15. Barmettler S
16. Bhar S
17. Bondarenko A
18. Bolyard AA
19. Buchbinder D
20. Cada M
21. Cavieres M
22. Connelly JA
23. Dale DC
24. Deordieva E
25. Dorsey MJ
26. Drysdale SB
27. Ehl S
28. Elfeky R
29. Fioredda F
30. Firkin F
31. Förster-Waldl E
32. Geng B
33. Goda V
34. Gonzalez-Granado L
35. Grunebaum E
36. Grzesk E
37. Henrickson SE
38. Hilfanova A
39. Hiwatari M
40. Imai C
41. Ip W
42. Jyonouchi S
43. Kanegane H
44. Kawahara Y
45. Khojah AM
46. Kim VH
47. Kojić M
48. Kołtan S
49. Krivan G
50. Langguth D
51. Lau YL
52. Leung D
53. Miano M
54. Mersyanova I
55. Mousallem T
56. Muskat M
57. Naoum FA
58. Noronha SA
59. Ouederni M
60. Ozono S
61. Richmond GW
62. Sakovich I
63. Salzer U
64. Schuetz C
65. Seeborg FO
66. Sharapova SO
67. Sockel K
68. Volokha A
69. von Bonin M
70. Warnatz K
71. Wegehaupt O
72. Weinberg GA
73. Wong KJ
74. Worth A
75. Yu H
76. Zharankova Y
77. Zhao X
78. Devlin L
79. Badarau A
80. Csomos K
81. Keszei M
82. Pereira J
83. Taveras AG
84. Beaussant-Cohen SL
85. Ong MS
86. Shcherbina A
87. Walter JE
Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.; Journal of clinical immunology. 2022 Aug 10.
1. Voll M
2. Fairclough DL
3. Morrato EH
4. McNeal DM
5. Embry L
6. Pelletier W
7. Noll RB
8. Sahler OJZ
Dissemination of an evidence-based behavioral intervention to alleviate distress in caregivers of children recently diagnosed with cancer: Bright IDEAS.; Pediatric blood & cancer; Vol 69(10), pp. e29904. 2022 Aug 04.
1. Tarlock K
2. Sulis ML
3. Chewning JH
4. Pollard JA
5. Cooper T
6. Gamis A
7. Shenoy S
8. Kutny M
9. Horan J
10. Meshinchi S
11. Boelens JJ
12. Bleakley M
13. Carpenter PA
14. Kolb EA
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.; Transplantation and cellular therapy; Vol 28(9), pp. 530-545. 2022 Jun 16.
1. Bouchard EG
2. Collins RL
3. Vincent PC
4. Patel H
5. Sahler O
6. McCarty C
7. Prince MA
8. Kelly KM
An initial investigation of using smartphone-enabled micro-temporal data collection to increase acceptability, feasibility, and validity of research on cancer caregiving; Pediatr Blood Cancer; Vol e29886, pp. 1-6. 2022 Jan 01.
1. Briere TM
2. Agrusa JE
3. Martel MK
4. Jackson A
5. Olch AJ
6. Ronckers CM
7. Kremer LCM
8. Constine LS
9. McAleer MF
Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 533-548. 2022 May 04.
1. Chandra B
2. Michmerhuizen NL
3. Shirnekhi HK
4. Tripathi S
5. Pioso BJ
6. Baggett DW
7. Mitrea DM
8. Iacobucci I
9. White MR
10. Chen J
11. Park CG
12. Wu H
13. Pounds S
14. Medyukhina A
15. Khairy K
16. Gao Q
17. Qu C
18. Abdelhamed S
19. Gorman SD
20. Bawa S
21. Maslanka C
22. Kinger S
23. Dogra P
24. Ferrolino MC
25. Di Giacomo D
26. Mecucci C
27. Klco JM
28. Mullighan CG
29. Kriwacki RW
Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.; Cancer discovery; Vol 12(4), pp. 1152-1169. 2022 Apr 01.
1. Lo AC
2. Major A
3. Super L
4. Appel B
5. Shankar A
6. Constine LS
7. Marks LJ
8. Kelly KM
9. Metzger ML
10. Buhtoiarov IN
11. Mauz-Körholz C
12. Costa ARS
13. Binkley MS
14. Flerlage J
Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).; Leukemia & lymphoma; Vol 63(8), pp. 1997-2000. 2022 Mar 31.
1. Atkins MH
2. Scarfò R
3. McGrath KE
4. Yang D
5. Palis J
6. Ditadi A
7. Keller GM
Modeling human yolk sac hematopoiesis with pluripotent stem cells.; The Journal of experimental medicine; Vol 219(3). 2022 Mar 07.
1. Noyes K
2. Zapf AL
3. Depner RN
4. Flores T
5. Huston A
6. Rashid HH
7. McNeal D
8. Constine LS
9. Fleming FJ
10. Wilding GE
11. Sahler O
Problem-solving skills training in adult cancer survivors: Bright IDEAS-AC pilot study; Cancer Treatment and Research Communications; Vol 31, pp. 1-7. 2022 Jan 01.
1. Michmerhuizen NL
2. Ludwig ML
3. Birkeland AC
4. Nimmagadda S
5. Zhai J
6. Wang J
7. Jewell BM
8. Genouw D
9. Remer L
10. Kim D
11. Foltin SK
12. Bhangale A
13. Kulkarni A
14. Bradford CR
15. Swiecicki PL
16. Carey TE
17. Jiang H
18. Brenner JC
Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma.; Head & neck; Vol 44(5), pp. 1192-1205. 2022 Feb 27.
1. Michmerhuizen NL
2. Heenan C
3. Wang J
4. Leonard E
5. Bellile E
6. Loganathan SK
7. Wong SY
8. Lei YL
9. Brenner JC
Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model.; Oral oncology; Vol 126, pp. 105770. 2022 Feb 13.
1. Nemkov T
2. Kingsley PD
3. Dzieciatkowska M
4. Malik J
5. McGrath K
6. Hansen KC
7. D'Alessandro A
8. Palis J
Circulating primitive murine erythroblasts undergo complex proteomic and metabolomic changes during terminal maturation.; Blood advances. 2022 Feb 09.
1. Qayed M
2. Watkins B
3. Gillespie S
4. Bratrude B
5. Betz K
6. Choi SW
7. Davis J
8. Duncan C
9. Giller R
10. Grimley M
11. Harris AC
12. Jacobsohn D
13. Lalefar N
14. Norkin M
15. Farhadfar N
16. Pulsipher MA
17. Shenoy S
18. Petrovic A
19. Schultz KR
20. Yanik GA
21. Waller EK
22. Langston A
23. Kean LS
24. Horan JT
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.; Blood advances; Vol 6(3), pp. 746-749. 2022 Feb 08.
1. Dvorak CC
2. Haddad E
3. Heimall J
4. Dunn E
5. Cowan MJ
6. Pai SY
7. Kapoor N
8. Satter LF
9. Buckley RH
10. O'Reilly RJ
11. Chandra S
12. Bednarski JJ
13. Williams O
14. Rayes A
15. Moore TB
16. Ebens CL
17. Davila Saldana BJ
18. Petrovic A
19. Chellapandian D
20. Cuvelier GDE
21. Vander Lugt MT
22. Caywood EH
23. Chandrakasan S
24. Eissa H
25. Goldman FD
26. Shereck E
27. Aquino VM
28. Desantes KB
29. Madden LM
30. Miller HK
31. Yu L
32. Broglie L
33. Gillio A
34. Shah AJ
35. Knutsen AP
36. Andolina JP
37. Joshi AY
38. Szabolcs P
39. Kapadia M
40. Martinez CA
41. Parrot RE
42. Sullivan KE
43. Prockop SE
44. Abraham RS
45. Thakar MS
46. Leiding JW
47. Kohn DB
48. Pulsipher MA
49. Griffith LM
50. Notarangelo LD
51. Puck JM
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.; The Journal of allergy and clinical immunology. 2022 Jan 28.
1. Parisi R
2. Patel RR
3. Rood G
4. Bowden A
5. Turco G
6. Korones DN
7. Andolina JR
8. Comito M
9. Barth M
10. Weintraub L
Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients.; Pediatric blood & cancer. 2022 Jan 26.
1. Stenger E
2. Xiang Y
3. Wetzel M
4. Gillespie S
5. Chellapandian D
6. Shah R
7. Arnold SD
8. Bhatia M
9. Chaudhury S
10. Eckrich MJ
11. Kanter J
12. Kasow KA
13. Krajewski J
14. Nickel RS
15. Ngwube AI
16. Olson TS
17. Rangarajan HG
18. Wobma H
19. Guilcher GMT
20. Horan JT
21. Krishnamurti L
22. Shenoy S
23. Abraham A
Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance.; Transplantation and cellular therapy; Vol 29(1), pp. 47.e1-47.e10. 2022 Jan 20.
1. Andolina JR
2. Wang YC
3. Ji L
4. Freyer DR
5. Levine JE
6. Pulsipher MA
7. Gamis AS
8. Aplenc R
9. Roth ME
10. Harrison L
11. Cairo MS
Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience.; Bone marrow transplantation; Vol 57(3), pp. 445-452. 2022 Jan 06.
1. Fries C
2. Lee LW
3. Devidas M
4. Dai Y
5. Rabin KR
6. Gupta S
7. Loh ML
8. Kirsch IR
9. Wood B
10. Rau RE
Prognostic impact of pre-treatment immunoglobulin clonal composition in pediatric Blymphoblastic leukemia.; Haematologica. 2022 Jan 03.
1. Fries C
2. Long AM
3. Marston BA
4. Andolina JR
Migratory Arthralgia in a 3-year-old Girl.; Pediatrics in review; Vol 43(1), pp. 41-44. 2022 Jan 01.
1. Chow EJ
2. Aplenc R
3. Vrooman LM
4. Doody DR
5. Huang YV
6. Aggarwal S
7. Armenian SH
8. Baker KS
9. Bhatia S
10. Constine LS
11. Freyer DR
12. Kopp LM
13. Leisenring WM
14. Asselin BL
15. Schwartz CL
16. Lipshultz SE
Late health outcomes after dexrazoxane treatment: a report from the Children's Oncology Group; Cancer; Vol 128(4), pp. 788-796. 2022 Jan 01.
1. Lipshultz ER
2. Chow EJ
3. Doody DR
4. Armenian SH
5. Asselin BL
6. Baker KS
7. Bhatia S
8. Constine LS
9. Freyer DR
10. Kopp LM
11. Schwartz CL
12. Lipshultz SE
13. Vrooman LM
Cardiometabolic risk in childhood cancer survivors: a report from the Children's Oncology Group; Cancer Epidemiol Biomarkers Prev; Vol 31(3), pp. 536-542. 2022 Jan 01.
1. Noyes K
2. Zapf AL
3. Depner RM
4. Flores T
5. Huston A
6. Rashid HH
7. McNeal D
8. Constine LS
9. Fleming FJ
10. Wilding GE
11. Sahler O
Problem-solving skills training in adult cancer survivors: Bright IDEAS-AC pilot study; Cancer Treat Res Commun; Vol 31. 2022 Jan 01.
1. Marchak JG
2. Christen S
3. Mulder RL
4. Baust K
5. Blom J
6. Brinkman TM
7. Elens I
8. Harju E
9. Kadan-Lottick NS
10. Khor J
11. Lemiere J
12. Recklitis CJ
13. Wakefield CE
14. Wiener L
15. Constine LS
16. Hudson MM
17. Kremer L
18. Skinner R
19. Vetsch J
20. Lee JL
21. Michel G
22. International GH
23. Group PL
24. effects G
Recommendations for the surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 23(4), pp. 184-196. 2022 Jan 01.
1. Lo AC
2. Major A
3. Super L
4. Appel B
5. Shankar A
6. Constine LS
7. Marks LJ
8. Kelly KM
9. Metzger ML
10. Buhtoiarov IN
11. Mauz-Körholz C
12. Costa A
13. Binkley MS
14. Flerlage J
Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW); Leuk Lymphoma; Vol 63(8), pp. 1997-2000. 2022 Jan 01.
1. Komisarof J
2. Lipof J
3. DiTursi J
4. Chowdhry A
5. Grace CH
6. Burack WR
7. Constine L
8. Passero F
An unusual case of multiple myeloma with light-chain cast nephropathy secondary to a very large plasmacytoma without bone marrow involvement; Case Rep Hematol; Vol 2022. 2022 Jan 01.
1. Hall MD
2. Terezakis SA
3. Lucas JT
4. Gallop-Evans E
5. Dieckmann K
6. Constine LS
7. Hodgson D
8. Flerlage JE
9. Metzger ML
10. Hoppe BS
Radiation Therapy Across Pediatric Hodgkin Lymphoma Research Group Protocols: A Report From the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group .; Int J Radiat Oncol Biol Phys; Vol 112(2), pp. 317-334. 2022 Jan 01.
1. Devine KA
2. Christen S
3. Mulder RL
4. Brown MC
5. Ingerski LM
6. Mader L
7. Potter E
8. Sleurs C
9. Viola A
10. Waern S
11. Constine LS
12. Hudson MM
13. Kremer L
14. Skinner R
15. Michel G
16. Marchak JG
17. Schulte F
18. on BO
19. the IP
20. late EG
Recommendations for the surveillance of education and employment outcomes in survivors of childhood, adolescent and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Cancer; Vol 128(13), pp. 2405-2419. 2022 Jan 01.
1. van Iersel L
2. Mulder RL
3. Denzer C
4. Cohen LE
5. Spoudeas HA
6. Meacham LR
7. Sugden E
8. Schouten-van MA
9. Hoving EW
10. Packer RJ
11. Armstrong GT
12. Mostoufi-Moab S
13. Stades AM
14. van Vuurden D
15. Janssens GO
16. Thomas-Teinturier C
17. Murray RD
18. Di Iorgi N
19. Neggers S
20. Thompson J
21. Toogood AA
22. Gleeson H
23. Follin C
24. Bardi E
25. Torno L
26. Patterson B
27. Morsellino V
28. Sommer G
29. Clement SC
30. Srivastava D
31. Kiserud CE
32. Fernandez A
33. Scheinemann K
34. Raman S
35. Yuen K
36. Wallace WH
37. Constine LS
38. et A
Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors; Endocr Rev; Vol 43(5), pp. 794-823. 2022 Jan 01.
1. McNeal DM
2. Sahler OJ
3. Noll RB
4. Fairclough DL
5. Voll ME
6. Bha TS
7. Morrato EH
Core functions and forms of Bright IDEAS: A multi-methods evaluation of the adoption of an evidence-based psychosocial training program through literative adaption; Frontiers in Health Services; Vol 96. 2022 Jan 01.
1. Alabdaljabar MS
2. Durani U
3. Thompson CA
4. Constine LS
5. Hashmi SK
The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship; Am J Hematol; Vol 97(12), pp. 1627-1637. 2022 Jan 01.
1. Parekh A
2. Keller FG
3. McCarten KM
4. Kessel S
5. Cho S
6. Pei Q
7. Wu Y
8. Castellino SM
9. Constine LS
10. Schwartz CL
11. Hodgson D
12. Kelly KM
13. Hoppe BS
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis; Blood; Vol 140(10), pp. 1086-1093. 2022 Jan 01.
1. Stephens DM
2. Li H
3. Constine LS
4. Fitzgerald TJ
5. Leonard JP
6. Kahl BS
7. Song JY
8. LeBlanc ML
9. Smith SM
10. Persky DO
11. Friedberg JW
Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001; Haematologica; Vol 107(11), pp. 2732-2736. 2022 Jan 01.
1. Dolgin MJ
2. Devine KA
3. Tzur-Bitan D
4. Askins MA
5. Fairclough DL
6. Katz ER
7. Noll RB
8. Phipps S
9. Sahler O
Responsivity to Problem-Solving Skills Training in Mothers of Children with Cancer; Oxford University Press; Journal of Pediatric Psychology; Vol 46(4), pp. 413-421. 2021 Jan 01.
1. Eastburg L
2. Russler-Germain DA
3. DiPersio JF
4. Fountaine T
5. Andolina JR
6. Abboud R
7. Huselton E
Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.; Leukemia & lymphoma. 2021 Nov 18.
1. Lo AC
2. Ronckers C
3. Aznar MC
4. Avanzo M
5. van Dijk I
6. Kremer LCM
7. Gagliardi G
8. Howell RM
9. Rancati T
10. Constine LS
11. Marcus KJ
Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 549-559. 2021 Oct 07.
1. Winter MA
2. Greelee J
3. Ghriwati NA
4. Garr KN
5. Sahler O
Children's appraisals of threat in pediatric cancer; SSM - Mental Health 1. 2021 Jan 01.
1. Zhang Y
2. McGrath KE
3. Ayoub E
4. Kingsley PD
5. Yu H
6. Fegan K
7. McGlynn KA
8. Rudzinskas S
9. Palis J
10. Perkins AS
Mds1CreERT2, an inducible Cre allele specific to adult-repopulating hematopoietic stem cells.; Cell reports; Vol 36(7). 2021 Aug 17.
1. Jeffery NN
2. Davidson C
3. Peslak SA
4. Kingsley PD
5. Nakamura Y
6. Palis J
7. Bulger M
Histone H2A.X phosphorylation and Caspase-Initiated Chromatin Condensation in late-stage erythropoiesis.; Epigenetics & chromatin; Vol 14(1). 2021 Jul 30.
1. Flerlage JE
2. Hiniker SM
3. Armenian S
4. Benya EC
5. Bobbey AJ
6. Chang V
7. Cooper S
8. Coulter DW
9. Cuglievan B
10. Hoppe BS
11. Isenalumhe L
12. Kelly K
13. Kersun L
14. Lamble AJ
15. Larrier NA
16. Magee J
17. Oduro K
18. Pacheco M
19. Price AP
20. Roberts KB
21. Smith CM
22. Sohani AR
23. Trovillion EM
24. Walling E
25. Xavier AC
26. Burns JL
27. Campbell M
Pediatric Hodgkin Lymphoma, Version 3.2021.; Journal of the National Comprehensive Cancer Network : JNCCN; Vol 19(6), pp. 733-754. 2021 Jun 30.
1. Saunders J
2. Niswander LM
3. McGrath KE
4. Koniski A
5. Catherman SC
6. Ture SK
7. Medhora M
8. Kingsley PD
9. Calvi LM
10. Williams JP
11. Morrell CN
12. Palis J
Long-acting PGE2 and Lisinopril Mitigate H-ARS.; Radiation research. 2021 Jun 21.
1. Fries C
2. Noronha SA
3. Metlay L
4. Zhang B
Transplacental transfer of congenital B-cell acute lymphoblastic leukemia to the maternal vasculature.; Pediatric blood & cancer; Vol 68(9), pp. e29142. 2021 Jun 14.
1. Farris N
2. Sampson M
Single-agent rituximab for treatment of multifocal and multiple relapsed pulmonary inflammatory myofibroblastic tumor in an adolescent patient.; Pediatric blood & cancer; Vol 68(9), pp. e29131. 2021 Jun 08.
1. Schenone D
2. Andolina JR
3. Rademacher B
4. Fountaine TJ
5. Edwards E
6. Nunez L
7. Qiu M
8. Sharma S
9. Mullen CA
Gene Expression and Survival of Acute Lymphoblastic Leukemia Cells After Allogeneic Transplant.; Anticancer research; Vol 41(6). 2021 Jun.
1. Milgrom SA
2. van Luijk P
3. Pino R
4. Ronckers CM
5. Kremer LC
6. Gidley PW
7. Grosshans DR
8. Laskar S
9. Okcu MF
10. Constine LS
11. Paulino AC
Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 467-481. 2021 May 29.
1. Kaplan FS
2. Teachey DT
3. Andolina JR
4. Siegel DM
5. Mancilla EE
6. Hsiao EC
7. Al Mukaddam M
8. Rocke DM
9. Pignolo RJ
Off-on-off-on use of imatinib in three children with fibrodysplasia ossificans progressiva.; Bone; Vol 150. 2021 May 19.
1. Fries C
2. Girvin AR
3. Korones DN
4. Weintraub L
5. Fitzpatrick L
6. Andolina JR
Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children.; Journal of pediatric hematology/oncology. 2021 May 18.
1. Casella JF
2. Barton BA
3. Kanter J
4. Black LV
5. Majumdar S
6. Inati A
7. Wali Y
8. Drachtman RA
9. Abboud MR
10. Kilinc Y
11. Fuh BR
12. Al-Khabori MK
13. Takemoto CM
14. Salman E
15. Sarnaik SA
16. Shah N
17. Morris CR
18. Keates-Baleeiro J
19. Raj A
20. Alvarez OA
21. Hsu LL
22. Thompson AA
23. Sisler IY
24. Pace BS
25. Noronha SA
26. Lasky JL
27. de Julian EC
28. Godder K
29. Thornburg CD
30. Kamberos NL
31. Nuss R
32. Marsh AM
33. Owen WC
34. Schaefer A
35. Tebbi CK
36. Chantrain CF
37. Cohen DE
38. Karakas Z
39. Piccone CM
40. George A
41. Fixler JM
42. Singleton TC
43. Moulton T
44. Quinn CT
45. de Castro Lobo CL
46. Almomen AM
47. Goyal-Khemka M
48. Maes P
49. Emanuele M
50. Gorney RT
51. Padgett CS
52. Parsley E
53. Kronsberg SS
54. Kato GJ
55. Gladwin MT
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.; JAMA; Vol 325(15), pp. 1513-1523. 2021 Apr 20.
1. Andolina JR
2. Fries C
3. Boulware R
4. Vargas A
5. Fraint E
6. Barth M
7. Abrusko S
8. Comito M
9. Monteleone P
Successful Bone Marrow Transplantation With Intensive Post-transplant Intrathecal Chemotherapy for CNS Relapsed AML in 2 Infants.; Journal of pediatric hematology/oncology. 2021 Apr 09.
1. Mahajan A
2. Stavinoha PL
3. Rongthong W
4. Brodin NP
5. McGovern SL
6. El Naqa I
7. Palmer JD
8. Vennarini S
9. Indelicato DJ
10. Aridgides P
11. Bowers DC
12. Kremer L
13. Ronckers C
14. Constine L
15. Avanzo M
Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 401-416. 2021 Mar 30.
1. Milano MT
2. Vargo JA
3. Yorke ED
4. Ronckers CM
5. Kremer LC
6. Chafe SMJ
7. van Santen HM
8. Marks LB
9. Bentzen SM
10. Constine LS
11. Vogelius IR
Primary Hypothyroidism in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics. 2021 Mar 17.
1. Constine LS
2. Olch AJ
3. Jackson A
4. Hua CH
5. Ronckers CM
6. Milano MT
7. Marcus KJ
8. Yorke E
9. Hodgson DC
10. Howell RM
11. Hudson MM
12. Williams JP
13. Marples B
14. C M Kremer L
15. Marks LB
16. Bentzen SM
Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Assess Normal Tissue Radiation Dose-Volume-Response Relationships for Children With Cancer.; International journal of radiation oncology, biology, physics. 2021 Mar 16.
1. Fries C
2. Evans AG
3. Cheon H
4. Korones DN
5. Loughran TP
6. Andolina JR
Allogeneic Bone Marrow Transplant as a Cure for Refractory T-Cell Large Granular Lymphocytic Leukemia in an Adolescent.; Journal of pediatric hematology/oncology; Vol 44(6), pp. e960-e963. 2021 Jan 29.
1. Smith SM
2. Zhang S
3. Sundaram V
4. Roth M
5. Andolina JR
6. Schapira L
7. Sakamoto KM
8. Kolb EA
9. Hijiya N
10. Chaudhury S
Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.; Pediatric hematology and oncology; Vol 39(5), pp. 453-467. 2021 Jan 17.
1. Watkins B
2. Qayed M
3. McCracken C
4. Bratrude B
5. Betz K
6. Suessmuth Y
7. Yu A
8. Sinclair S
9. Furlan S
10. Bosinger S
11. Tkachev V
12. Rhodes J
13. Tumlin AG
14. Narayan A
15. Cribbin K
16. Gillespie S
17. Gooley TA
18. Pasquini MC
19. Hebert K
20. Kapoor U
21. Rogatko A
22. Tighiouart M
23. Kim S
24. Bresee C
25. Choi SW
26. Davis J
27. Duncan C
28. Giller R
29. Grimley M
30. Harris AC
31. Jacobsohn D
32. Lalefar N
33. Norkin M
34. Farhadfar N
35. Pulsipher MA
36. Shenoy S
37. Petrovic A
38. Schultz KR
39. Yanik GA
40. Waller EK
41. Levine JE
42. Ferrara JL
43. Blazar BR
44. Langston A
45. Horan JT
46. Kean LS
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 39(17), pp. 1865-1877. 2021 Jan 15.
1. Avutu V
2. Monga V
3. Mittal N
4. Saha A
5. Andolina JR
6. Bell DE
7. Fair DB
8. Flerlage JE
9. Frediani JN
10. Heath JL
11. Kahn JM
12. Reichek JL
13. Super L
14. Terao MA
15. Freyer DR
16. Roth ME
Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.; JCO oncology practice; Vol 18(3), pp. 224-231. 2021 Jan 14.
1. Tkachev V
2. Kaminski J
3. Potter EL
4. Furlan SN
5. Yu A
6. Hunt DJ
7. McGuckin C
8. Zheng H
9. Colonna L
10. Gerdemann U
11. Carlson J
12. Hoffman M
13. Olvera J
14. English C
15. Baldessari A
16. Panoskaltsis-Mortari A
17. Watkins B
18. Qayed M
19. Suessmuth Y
20. Betz K
21. Bratrude B
22. Langston A
23. Horan JT
24. Ordovas-Montanes J
25. Shalek AK
26. Blazar BR
27. Roederer M
28. Kean LS
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.; Science translational medicine; Vol 13(576). 2021 Jan 13.
1. Meier ER
2. Abraham AA
3. Ngwube A
4. Janson IA
5. Guilcher GMT
6. Horan J
7. Kasow KA
Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study.; Pediatric blood & cancer; Vol 68(3), pp. e28861. 2021 Jan 06.
1. Bowers DC
2. Verbruggen LC
3. Kremer L
4. Hudson MM
5. Skinner R
6. Constine LS
7. Sabin ND
8. Bhangoo R
9. Haupt R
10. Hawkins MM
11. Jenkinson H
12. Khan RB
13. Klimo JP
14. Pretorius P
15. Ng A
16. Reulen RC
17. Ronckers CM
18. Sadighi Z
19. Scheinemann K
20. Schouten-van MN
21. Sugden E
22. Teepen JC
23. Ullrich NJ
24. Walter A
25. Wallace WH
26. Oeffinger KC
27. Armstrong GT
28. van der PH
29. Mulder RL
Surveillance for subsequent neoplasms of the central nervous system for childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 22(5), pp. 196-206. 2021 Jan 01.
1. Oeffinger KC
2. Stratton KL
3. Hudson MM
4. Leisenring WM
5. Henderson TO
6. Howell RM
7. Wolden SL
8. Constine LS
9. Diller LR
10. Sklar CA
11. Nathan PC
12. Castellino SM
13. Barnea D
14. Smith SA
15. Hutchinson RJ
16. Armstrong GT
17. Robison LL
Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study; J Clin Oncol; Vol 39(20), pp. 2266-2275. 2021 Jan 01.
1. Hoppe BS
2. Advani R
3. Milgrom SA
4. Bakst RL
5. Ballas LK
6. Dabaja BS
7. Flowers CR
8. Ha CS
9. Mansur DB
10. Metzger ML
11. Pinnix CC
12. Plastaras JP
13. Roberts KB
14. Smith SM
15. Terezakis SA
16. Kirwan JM
17. Constine LS
Primary Mediastinal B cell Lymphoma in the Positron-Emission Tomography Era: Executive Summary of the American Radium Society Appropriate Use Criteria; Int J Radiat Oncol Biol Phys; Vol 111(1), pp. 36-44. 2021 Jan 01.
1. Mulder RL
2. Font-Gonzalez A
3. Hudson MM
4. van Santen HM
5. Loeffen E
6. Burns KC
7. Quinn GP
8. van Dulmen-den BE
9. Byrne J
10. Haupt R
11. Wallace WH
12. van den HM
13. Anazodo A
14. Anderson RA
15. Barnbrock A
16. Beck JD
17. Bos A
18. Demeestere I
19. Denzer C
20. Di Iorgi N
21. Hoefgen HR
22. Kebudi R
23. Lambalk C
24. Langer T
25. Meacham LR
26. Rodriguez-Wallberg K
27. Stern C
28. Stutz-Grunder E
29. van Dorp W
30. Veening M
31. Veldkamp S
32. van der ME
33. Constine LS
34. Kenney LB
35. van de WM
36. Kremer L
37. Levine J
38. Tissing W
39. PanCareLIFE C
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.; Lancet Oncol; Vol 22(2), pp. 45-56. 2021 Jan 01.
1. Mulder RL
2. Font-Gonzalez A
3. Green DM
4. Loeffen E
5. Hudson MM
6. Loonen J
7. Yu R
8. Ginsberg JP
9. Mitchell RT
10. Byrne J
11. Skinner R
12. Anazodo A
13. Constine LS
14. de Vries A
15. Jahnukainen K
16. Lorenzo A
17. Meissner A
18. Nahata L
19. Dinkelman-Smit M
20. Tournaye H
21. Haupt R
22. van den HM
23. van Santen HM
24. van Pelt A
25. Dirksen U
26. den HJ
27. van Dulmen-den BE
28. Wallace WH
29. Levine J
30. Tissing W
31. Kremer L
32. Kenney LB
33. van de WM
34. PanCareLIFE C
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 22(2), pp. 57-67. 2021 Jan 01.
1. Dorsey MJ
2. Wright NAM
3. Chaimowitz NS
4. Dávila Saldaña BJ
5. Miller H
6. Keller MD
7. Thakar MS
8. Shah AJ
9. Abu-Arja R
10. Andolina J
11. Aquino V
12. Barnum JL
13. Bednarski JJ
14. Bhatia M
15. Bonilla FA
16. Butte MJ
17. Bunin NJ
18. Chandra S
19. Chaudhury S
20. Chen K
21. Chong H
22. Cuvelier GDE
23. Dalal J
24. DeFelice ML
25. DeSantes KB
26. Forbes LR
27. Gillio A
28. Goldman F
29. Joshi AY
30. Kapoor N
31. Knutsen AP
32. Kobrynski L
33. Lieberman JA
34. Leiding JW
35. Oshrine B
36. Patel KP
37. Prockop S
38. Quigg TC
39. Quinones R
40. Schultz KR
41. Seroogy C
42. Shyr D
43. Siegel S
44. Smith AR
45. Torgerson TR
46. Vander Lugt MT
47. Yu LC
48. Cowan MJ
49. Buckley RH
50. Dvorak CC
51. Griffith LM
52. Haddad E
53. Kohn DB
54. Logan B
55. Notarangelo LD
56. Pai SY
57. Puck J
58. Pulsipher MA
59. Heimall J
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.; Journal of clinical immunology; Vol 41(1). 2021 Jan.
1. Kumar A
2. Casulo C
3. Advani RH
4. Budde E
5. Barr PM
6. Batlevi CL
7. Caron P
8. Constine LS
9. Dandapani SV
10. Drill E
11. Drullinsky P
12. Friedberg JW
13. Grieve C
14. Hamilton A
15. Hamlin PA
16. Hoppe RT
17. Horwitz SM
18. Joseph A
19. Khan N
20. Laraque L
21. Matasar MJ
22. Moskowitz AJ
23. Noy A
24. Palomba M
25. Schroder H
26. Straus DJ
27. Vemuri S
28. Yang J
29. Younes A
30. Zelenetz AD
31. Yahalom J
32. Moskowitz CH
Brentuximab Vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma; J Clin Oncol; Vol 39(20), pp. 2257-2265. 2021 Jan 01.
1. Cohen-Cutler S
2. Olch A
3. Wong K
4. Malvar J
5. Sposto R
6. Kobierski P
7. Sura A
8. Constine LS
9. Freyer DR
Surveillance for radiation-related late effects in childhood cancer survivors: the impact of using volumetric dosimetry; Cancer Med; Vol 10, pp. 905-913. 2021 Jan 01.
1. Ballas LK
2. Metzger ML
3. Milgrom SA
4. Advani R
5. Bakst RL
6. Dabaja BS
7. Flowers CR
8. Ha CS
9. Hoppe BS
10. Mansur DB
11. Pinnix CC
12. Plastaras JP
13. Roberts KB
14. Smith SN
15. Terezakis SA
16. Constine LS
Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American Radium Society appropriate use criteria; Leuk Lymphoma; Vol 62(5), pp. 1057-1065. 2021 Jan 01.
1. Giulino-Roth L
2. Pei Q
3. Buxton A
4. Bush R
5. Wu Y
6. Wolden SL
7. Constine LS
8. Kelly KM
9. Schwartz CL
10. Friedman DL
Subsequent malignant neoplasms among children with Hodgkin lymphoma: A report from the Children's Oncology Group; Blood; Vol 137(11), pp. 1449-1456. 2021 Jan 01.
1. van der KA
2. Mulder RL
3. Hudson MM
4. Kremer L
5. Skinner R
6. Constine LS
7. van Dorp W
8. van Dulmen-den BE
9. Winther JF
10. Wallace WH
11. Waugh J
12. Woodruff TK
13. Anderson RA
14. Armenian SH
15. Bloemenkamp K
16. Critchley H
17. Demoor-Goldschmidt C
18. Ehrhardt MJ
19. Green DM
20. Grobman WA
21. Iwahata Y
22. Krishna I
23. Laven J
24. Levitt G
25. Meacham LR
26. Miller ES
27. Mulders A
28. Polanco A
29. Ronckers CM
30. Samuel A
31. Walwyn T
32. van den HM
33. Levine JM
Counseling and surveillance of obstetric risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Am J Obstet Gynecol; Vol 224(1), pp. 3-15. 2021 Jan 01.